Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults.

A secondary analysis of NCT00422058. The report of the trial’s main result is not on the map, and the numbers here are shown and do not vote.

What the trial testedrandomised · 564 people · 2014

Randomised comparison

Doesn’t vote: a later paper about the trial

+2.90kg+0.50 to +5.30

As reported

difference 2.9 kg, 95% CI 0.50–5.30

the abstract, start to end

… with none (a treatment difference of 2.9 kg (95% confidence interval …

← favours treatmentfavours comparator →

could be chance

Adverse events & safety

2.90.50–5.30

GLP-1 receptor agonistsAdverse events & safety

1 / 3

2014

…

2015

2016

2017

2019

2020

2021

2022

2023

2024

2025

2026

this paperpooled ittrialcites it